Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2008. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2690322016 | Parenteral form topotecan (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2694926018 | Parenteral form topotecan | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3487388013 | Product containing topotecan in parenteral dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3495754018 | Topotecan in parenteral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3495755017 | Product containing topotecan in parenteral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3712208016 | Product containing topotecan in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3712209012 | Topotecan-containing product in parenteral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing topotecan in parenteral dose form (medicinal product form) | Is a | Product containing topotecan | true | Inferred relationship | Existential restriction modifier | ||
| Product containing topotecan in parenteral dose form (medicinal product form) | Has active ingredient | Topotecan | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing topotecan in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing topotecan in parenteral dose form (medicinal product form) | Is a | Product manufactured as parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing topotecan in parenteral dose form (medicinal product form) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely topotecan (as topotecan hydrochloride) 4 milligram/1 vial powder for conventional release solution for injection | Is a | False | Product containing topotecan in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing precisely topotecan (as topotecan hydrochloride) 1 milligram/1 vial powder for conventional release solution for injection | Is a | False | Product containing topotecan in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing only topotecan in parenteral dose form (medicinal product form) | Is a | True | Product containing topotecan in parenteral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR